Cipla Pharmaceuticals Limited

U24239MH2019PLC333266ActivePublic · Non-govt companyRoC-MumbaiUnlisted
Last updated: 2026-06-08
67
Compliance Health · C · provisional
3 / 4 signals passed

Cipla Pharmaceuticals Limited is a Public Non-govt company company incorporated in 2019 and based in Maharashtra, India. It was founded by Rajendra. Cipla Pharmaceuticals Limited operates in Hina powder, manufacturing (NIC 24239) with authorized capital of ₹35.00 Cr and paid-up capital of ₹35.00 Cr. For 2022-23, the company reported revenue of ₹0 and a net loss of ₹91.77 L. The board has 2 active directors. RegisterKaro's provisional Compliance Health Score for the company is 67/100 (grade C), based on 4 of 9 signals — full scoring is pending extraction of the company's MCA filing history.

Risk FlagsAGM 1799d ago · may be overdue
Revenue (latest FY)
₹0
2022-23
PAT (latest FY)
₹-91.77 L
Awaiting extraction
Open Charges
0
No encumbrances
Active Directors
2
No resignations
Paid-up Capital
₹35.00 Cr
100% of authorized
Filings on Record
0
All current
Incorporated
2019
7 years old
State
Maharashtra
Sector
Hina powder, manufacturing
NIC 24239
Class
Public
Sub-category
Non-govt company
Authorized Capital
₹35.00 Cr
Paid-up Capital
₹35.00 Cr
100% utilized
Members
Last AGM
27 Sept 2021
1799d ago
Last Balance Sheet
31 Mar 2021
1979d ago
Latest Filing
Registered Email
c****************(at)cipla.com
Registered Office
Tower A, 1st Floor, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai Mumbai City MH 400013 IN
CIPLA PHARMACEUTICALS LIMITED
Brand CIPLA PHARMACEUTICALS LIMITED · Legal entity Cipla Pharmaceuticals Limited

CIPLA PHARMACEUTICALS LIMITED is the legal entity of Cipla.

Total Funding
Latest Round
Revenue
Valuation
Funding Rounds
Employees
78
Stage
Public
HQ
Founded
2019
Joined to MCA on CIN U24239MH2019PLC333266

Quick facts

Identity · Activity · Auditor · Contact
Registered office
Tower A, 1st Floor, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai Mumbai City MH 400013 IN
NIC code
24239
Statutory auditor
Awaiting ADT-1 / AOC-4 extraction
Registered email
c****************(at)cipla.com
Section
Hina powder, manufacturing
ROC
RoC-Mumbai
Website
Class · sub-category
Public · Non-govt company
Incorporation · Last AGM
19 Nov 2019 · 27 Sept 2021

Directors

2 activeNo resignations on record

MCA Filings

AOC-4 · MGT-7 historyLocked
FormFYFiledDueDelayStatus
AOC-4FY2024-2530 Oct 202430 Oct 20240dfiled
MGT-7FY2024-2527 Nov 202429 Nov 20240dfiled
AOC-4FY2023-2430 Oct 202330 Oct 2023+26dfiled
MGT-7FY2023-2421 Nov 202329 Nov 20230dfiled
AOC-4FY2022-2330 Oct 202230 Oct 20220dfiled
MGT-7FY2022-2323 Nov 202229 Nov 20220dfiled
Get financial statements & other filing documents

Full MCA filing history for Cipla Pharmaceuticals Limited.

₹499₹169(excl. taxes)
What you'll get
  • Incorporation Documents
  • Change in Directors & Designated Partner
  • Board Resolutions
  • Financial Statements & Annual Filings
  • Charge Documents (Summary)

Charges

Registered charges & encumbrancesLocked
Charge IDHolderAmountCreatedStatus
498044762ICICI Bank Ltd(Bank)₹14.05 Cr27 Jan 2021Open
762575573Kotak Mahindra Bank Ltd(Bank)₹15.97 Cr27 Jan 2023Open
915662869ICICI Bank Ltd(Bank)₹11.53 Cr04 Jul 2022Open
606121709HDFC Bank Ltd(Bank)₹24.84 Cr19 Sep 2019Satisfied
846675175HDFC Bank Ltd(Bank)₹16.13 Cr12 Mar 2023Satisfied
320707080ICICI Bank Ltd(Bank)₹12.27 Cr04 Jul 2020Satisfied
See registered charges & lenders

Charge IDs, lenders & amounts for Cipla Pharmaceuticals Limited.

₹499₹169(excl. taxes)
What you'll get
  • Incorporation Documents
  • Change in Directors & Designated Partner
  • Board Resolutions
  • Financial Statements & Annual Filings
  • Charge Documents (Summary)

Financial Performance

MCA1 reporting year
Revenue (bars) vs PAT (line) by FY
Revenue PAT
₹0₹0₹1₹1₹02022-23
FYRevenuePATNet WorthTotal AssetsEmployees
2022-23

Detailed Financials

1 FYsIncome statement + balance sheet
Line item2022-23
Income statement
Revenue from operations
Other income
Total income
Total expenses
Profit before tax
Profit / (Loss) after tax
Balance sheet
Equity / Net worth
Borrowings
Current liabilities
Total liabilities
Current assets
Cash & equivalents
Total assets
Employees

Cash-flow statement renders when the AOC-4 XBRL Cash Flow context is parsed during the extract phase.

Compounded Annual Growth Rate

Derived from multi-FY filingsLocked
MetricLatest value1Y CAGR3Y CAGR5Y CAGR
Revenue₹78.96 Cr+19.1%+16.5%+12.7%
Profit after Tax₹-5.68 Cr-8.2%+10.1%+11.5%
Net Worth₹34.83 Cr+7.1%+21.0%+1.5%
Employees322+2.8%+1.4%-0.7%
Gain deeper financial insights of this entity

Audited financials & ratios for Cipla Pharmaceuticals Limited.

₹999₹249(excl. taxes)
What you'll get
  • Financial Summary & Charts
  • Income Statement, Balance Sheet, Cashflow
  • Profitability, Liquidity & Growth Ratios
  • Audited Financial Statement (AOC-4)

Financial Ratios

Profitability · leverage · efficiency
FYRevenuePATPAT marginRev growthROEROAD/ERev/emp
2022-23-1.14%-1.10%0.04

Cap Table & Shareholding

Promoter · institutional · publicLocked
CategoryShareholdersShares held%
Promoters43,45,86,15890.06%
Institutional Investors114,22,9793.71%
Public & Others5723,95,5436.24%
See the full shareholding pattern

Promoter, institutional & public holding for Cipla Pharmaceuticals Limited.

₹499₹169(excl. taxes)
What you'll get
  • Incorporation Documents
  • Change in Directors & Designated Partner
  • Board Resolutions
  • Financial Statements & Annual Filings
  • Charge Documents (Summary)

Peer Benchmark

33 peersSame sector + state + ±5y vintage
MetricThis companyCohort medianCohort P75Quartile
Revenue (latest FY)
PAT (latest FY)
Bottom quartile · P0
Employees
Paid-up capital
Top quartile · P100
Compliance Health
96
96
96
Bottom quartile · P9

Top 10 in Hina powder, manufacturing

by healthView all ›
01
Paid-up
Revenue
A · 96
02
Cipla Limited
Maharashtra · Inc 1935
Paid-up
Revenue
A · 96
03
Paid-up
Revenue
A · 96
04
Paid-up
Revenue
A · 96
05
Macleods Pharmaceuticals Ltd
Maharashtra · Inc 1989
Paid-up
Revenue
A · 96
06
Aurobindo Pharma Ltd
Telangana · Inc 1986
Paid-up
Revenue
A · 96
07
Paid-up
Revenue
A · 96
08
Rampex Labs Private Limited
Telangana · Inc 2004
Paid-up
Revenue
A · 96
09
Sanofi India Limited
Maharashtra · Inc 1956
Paid-up
Revenue
A · 96
10
Visakha Pharmacity Limited
Telangana · Inc 2004
Paid-up
Revenue
A · 96

Events & timeline

3Filings, charges, board changes
27 Sept 2021
Anisha appointed as Director
19 Nov 2019
Company incorporated
Cipla Pharmaceuticals Limited registered with RoC-Mumbai; year 2019
19 Nov 2019
Rajendra appointed as Director

External data sources

7 plannedWhat lands here as ingestion comes online

GSTIN Registrations

Planned
GST portal

Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.

MSME Payment Delays

Planned
MSME-1 form

Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.

Related Party Transactions

Planned
AOC-4 schedule

Counterparty, nature, transaction value. Inter-company loans, sales, royalty.

Credit Ratings

Planned
CRISIL / ICRA / CARE feeds

Long-term + short-term ratings, with rationale on rating actions.

Trademarks

Planned
IP India Trademark Registry

Applied, registered, opposed. Class numbers + status.

Patents

Planned
IP India Patent Registry

Applications and grants. Inventor names + filing dates.

Legal Cases

Planned
eCourts + Indian Kanoon

Ongoing + past litigations the entity is party to.

Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.

FAQs about Cipla Pharmaceuticals Limited

When was Cipla Pharmaceuticals Limited incorporated?
Cipla Pharmaceuticals Limited was incorporated in 2019 (around 19 Nov 2019). Its CIN is U24239MH2019PLC333266 and it is registered with RoC-Mumbai.
Where is Cipla Pharmaceuticals Limited located?
Cipla Pharmaceuticals Limited is headquartered in Maharashtra, at: Tower A, 1st Floor, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai Mumbai City MH 400013 IN .
What sector does Cipla Pharmaceuticals Limited operate in?
Cipla Pharmaceuticals Limited operates in the Hina powder, manufacturing sector (NIC code 24239), classified as Non-govt company.
Who are the directors of Cipla Pharmaceuticals Limited?
Cipla Pharmaceuticals Limited has 2 active directors: Anisha (Director), Rajendra (Director).
What is the paid-up capital of Cipla Pharmaceuticals Limited?
Cipla Pharmaceuticals Limited has authorized capital of ₹35.00 Cr and paid-up capital of ₹35.00 Cr.
Does Cipla Pharmaceuticals Limited have any open charges?
Cipla Pharmaceuticals Limited has no open MCA-registered charges on record.
What is Cipla Pharmaceuticals Limited's Compliance Health Score?
RegisterKaro's Compliance Health Score for Cipla Pharmaceuticals Limited is 67/100 (grade C), based on 4 assessable weighted signals across charges, directors, capital, and overall status. 3 of 4 passed — this is a provisional score; full scoring is pending extraction of the company's MCA filing history.